NCT02971436

Brief Summary

This study will investigate the efficacy of the FPH modified positive airway pressure (PAP) device with or without SensAwake; and with different pressure support in OSA participants; in both an in-home and in-lab environment. Comfort, compliance and the accuracy of the pressure delivery will also be evaluated. The FPH device will be compared to a market released product.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 23, 2016

Completed
8 days until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2017

Completed
Last Updated

August 2, 2018

Status Verified

August 1, 2018

Enrollment Period

9 months

First QC Date

November 17, 2016

Last Update Submit

August 1, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Apnea Hypopnea Index (AHI)

    Through the device and independent flow logger

    3 nights

  • Apnea Hypopnea Index (AHI)

    Through the polysomnography

    1 night

Secondary Outcomes (4)

  • Therapy Comfort

    3 nights

  • Compliance

    3 nights

  • Device Triggering

    3 nights

  • Device Triggering

    1 night

Study Arms (6)

FPH Device with SensAwake On + Pressure Support A

ACTIVE COMPARATOR

FPH Device with SensAwake On + Pressure Support A

Device: FPH Device with SensAwake On + Pressure Support A

FPH Device with SensAwake Off + Pressure Support A

ACTIVE COMPARATOR

FPH Device with SensAwake Off + Pressure Support A

Device: FPH Device with SensAwake Off + Pressure Support A

FPH Device with SensAwake On + Pressure Support B

ACTIVE COMPARATOR

FPH Device with SensAwake On + Pressure Support B

Device: FPH Device with SensAwake On + Pressure Support B

FPH Device with SensAwake Off + Pressure Support B

ACTIVE COMPARATOR

FPH Device with SensAwake Off + Pressure Support B

Device: FPH Device with SensAwake Off + Pressure Support B

Competitor's PAP Released Device + Pressure Support A

ACTIVE COMPARATOR

Competitor's PAP Released Device + Pressure Support A

Device: Competitor's PAP Released Device + Pressure Support A

Competitor's PAP Released Device + Pressure Support B

ACTIVE COMPARATOR

Competitor's PAP Released Device + Pressure Support B

Device: Competitor's PAP Released Device + Pressure Support B

Interventions

FPH Device with SensAwake On + Pressure Support A

FPH Device with SensAwake On + Pressure Support A

FPH Device with SensAwake Off + Pressure Support A

FPH Device with SensAwake Off + Pressure Support A

FPH Device with SensAwake On + Pressure Support B

FPH Device with SensAwake On + Pressure Support B

FPH Device with SensAwake Off + Pressure Support B

FPH Device with SensAwake Off + Pressure Support B

Competitor's PAP Released Device + Pressure Support A

Competitor's PAP Released Device + Pressure Support A

Competitor's PAP Released Device + Pressure Support B

Competitor's PAP Released Device + Pressure Support B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 and over
  • Diagnosed with OSA by a practicing physician and prescribed Positive Airway Pressure (PAP) - (Continuous Positive Airway Pressure (CPAP) or AutoCPAP). Participants can be naïve to CPAP or experienced users of CPAP.
  • For experienced users of PAP (CPAP or AutoCPAP): Using the PAP of more than 4 hours/night for 70% during the last 30 days (justification allowed by the investigator)

You may not qualify if:

  • Contraindicated for PAP (CPAP or AutoCPAP) therapy
  • Persons with other significant sleep disorder(s) (e.g periodic leg movements, insomnia, central sleep apnea)
  • Persons with obesity hypoventilation syndrome or congestive heart failure.
  • Persons that require supplemental oxygen with their PAP (CPAP or AutoCPAP) device
  • Persons with implanted electronic medical device (e.g cardiac pacemakers)
  • Persons who are pregnant or think they might be pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fisher & Paykel Healthcare

Auckland, 0600, New Zealand

Location

WellSleep Centre

Wellington, 6035, New Zealand

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2016

First Posted

November 23, 2016

Study Start

December 1, 2016

Primary Completion

August 31, 2017

Study Completion

August 31, 2017

Last Updated

August 2, 2018

Record last verified: 2018-08

Locations